Michael A. Hollingsworth
Affiliations: | University of Nebraska Medical Center, Omaha, NE, United States |
Area:
BiochemistryWebsite:
https://www.unmc.edu/eppley/about/faculty/hollingsworth.htmlGoogle:
"Michael Hollingsworth"Bio:
https://books.google.com/books?id=pJYvAQAAIAAJ
Mean distance: (not calculated yet)
Parents
Sign in to add mentorDonald L. Evans | grad student | 1982 | Wake Forest School of Medicine | |
(Characterization of spleen cell proliferative responses, resistance to syngeneic tumor growth, and immunoregulatory activity in aging New Zealand black rats.) |
Children
Sign in to add trainee
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Dailey KM, Small JM, Pullan JE, et al. (2023) An intravenous pancreatic cancer therapeutic: Characterization of CRISPR/Cas9n-modified Clostridium novyi-Non Toxic. Plos One. 18: e0289183 |
Zheng D, Grandgenett PM, Zhang Q, et al. (2023) radioGWAS: link radiome to genome to discover driver genes with somatic mutations for heterogeneous tumor image phenotype in pancreatic cancer. Medrxiv : the Preprint Server For Health Sciences |
Yu SY, Luan Y, Tang S, et al. (2023) Uncovering Tumor-Promoting Roles of Activin A in Pancreatic Ductal Adenocarcinoma. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2207010 |
Mullen NJ, Shukla SK, Thakur R, et al. (2023) DHODH inhibition enhances the efficacy of immune checkpoint blockade by increasing cancer cell antigen presentation. Biorxiv : the Preprint Server For Biology |
Mondal P, Patel NS, Bailey K, et al. (2022) Induction of pancreatic neoplasia in the KRAS/TP53 Oncopig. Disease Models & Mechanisms |
Vance K, Alitinok A, Winfree S, et al. (2022) Erratum to: Machine learning analyses of highly-multiplexed immunofluorescence identifies distinct tumor and stromal cell populations in primary pancreatic tumors. Cancer Biomarkers : Section a of Disease Markers |
Rajesh C, Sagar S, Rathinavel AK, et al. (2022) Truncated O-Glycan-Bearing MUC16 Enhances Pancreatic Cancer Cells Aggressiveness via α4β1 Integrin Complexes and FAK Signaling. International Journal of Molecular Sciences. 23 |
Napoleon JV, Sagar S, Kubica SP, et al. (2022) Small-molecule IKKβ activation modulator (IKAM) targets MAP3K1 and inhibits pancreatic tumor growth. Proceedings of the National Academy of Sciences of the United States of America. 119: e2115071119 |
Ganguly K, Cox JL, Ghersi D, et al. (2022) Mucin 5AC-mediated CD44/ITGB1 clustering mobilizes adipose-derived mesenchymal stem cells to modulate pancreatic cancer stromal heterogeneity. Gastroenterology |
Vance K, Alitinok A, Winfree S, et al. (2022) Machine learning analyses of highly-multiplexed immunofluorescence identifies distinct tumor and stromal cell populations in primary pancreatic tumors. Cancer Biomarkers : Section a of Disease Markers. 33: 219-235 |